2026-08-27 · GLP-1, tirzepatide, semaglutide, birth control, oral contraceptives, drug interaction, Zepbound, Mounjaro, Wegovy, Ozempic

Does Ozempic (semaglutide) affect birth control pills?

Ozempic does not carry a labeled oral-contraceptive interaction in the Novo Nordisk semaglutide prescribing information, and the injectable-semaglutide pharmacokinetic data do not show the same magnitude of oral-contraceptive absorption reduction that tirzepatide does. That said, semaglutide slows gastric emptying by roughly 30 to 70 minutes at therapeutic doses (Blundell 2017, Diabetes Obesity and Metabolism), and any GLP-1 that produces persistent vomiting in the first weeks of titration can reduce oral-contraceptive efficacy the same way a stomach bug would. Practical guidance: if you are on Ozempic and want extra confidence, add a barrier method for 4 weeks after each dose step-up, or discuss switching to a non-oral hormonal method with your prescriber.

Does Mounjaro or Zepbound (tirzepatide) affect birth control pills?

Yes. The Eli Lilly tirzepatide prescribing information (Section 7, Drug Interactions) documents an approximately 20 percent reduction in oral-contraceptive area-under-the-curve and roughly a 55 percent reduction in peak concentration after a single 5 mg dose of tirzepatide in the Rasa 2023 pharmacokinetic study of norgestimate plus ethinyl estradiol. The label formally recommends switching to a non-oral hormonal contraceptive or adding a barrier method for 4 weeks after starting Mounjaro or Zepbound and for 4 weeks after each dose escalation. The mechanism is delayed gastric emptying flattening the oral-contraceptive absorption curve during the days when gastric-emptying delay is largest.

How long do I need backup birth control after starting or increasing my GLP-1 dose?

For tirzepatide (Mounjaro, Zepbound), the label specifies 4 weeks after initiation and 4 weeks after each dose escalation. Because tirzepatide titrates from 2.5 mg to 5, 7.5, 10, 12.5, and 15 mg with a step-up roughly every 4 weeks, that can effectively mean continuous barrier backup or a non-oral method across the whole titration period for many patients. For semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and dulaglutide (Trulicity), there is no labeled backup requirement — but a 4-week barrier window after each escalation is a reasonable conservative default if you rely on an oral contraceptive.

Are IUDs affected by GLP-1 medications?

No. Intrauterine devices — the copper IUD (Paragard) and the levonorgestrel IUDs (Mirena, Liletta, Kyleena, Skyla) — release contraceptive locally in the uterus and do not depend on gastrointestinal absorption. Neither delayed gastric emptying from a GLP-1 nor vomiting affects IUD efficacy. The same is true for the subdermal implant (Nexplanon), the depot injection (Depo-Provera), the transdermal patch (Xulane, Twirla), and the vaginal ring (NuvaRing, Annovera). Any of these non-oral hormonal options bypasses the GLP-1-and-oral-contraceptive issue entirely and is often the simplest long-term move for readers who plan to stay on a GLP-1 beyond 6 months.

What if I vomit or have diarrhea after taking my birth-control pill on a GLP-1?

If you vomit within 3 hours of taking a combined oral contraceptive or a progestin-only pill, the dose likely did not absorb — treat the day as a missed pill and follow the missed-pill instructions on your specific pill pack (usually take another pill from a backup pack and continue on schedule, with barrier backup for 7 days). Diarrhea alone does not usually require missed-pill action unless it is severe or prolonged. Vomiting is a common side effect in the first 4 to 8 weeks of any GLP-1 titration and after each dose escalation, so having a barrier method on hand during those windows is a practical default.

Can I get pregnant on a GLP-1?

Yes. Pregnancy is possible on any GLP-1, and multiple case series and postmarketing reports since 2022 describe unintended pregnancies in women who thought a GLP-1 was itself contraceptive or who did not know about the tirzepatide oral-contraceptive interaction. All approved GLP-1s (Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza, Trulicity) are contraindicated during pregnancy, so contraception matters more on a GLP-1, not less. Use the specific per-drug guidance above and — if your prescriber has not raised this — bring it up at your next visit.

How long should I stop my GLP-1 before trying to get pregnant?

The Novo Nordisk and Eli Lilly labels for Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda all recommend discontinuation at least 2 months before planned conception. This washout is driven by drug half-life: semaglutide has a half-life of roughly 7 days, tirzepatide roughly 5 days, and liraglutide roughly 13 hours. Two months clears semaglutide and tirzepatide to about 5 percent of steady-state concentration and gives the reproductive system a stable pre-conception window. Plan a stop-date with your prescriber; a surprise stop-and-conceive is not the same conversation.

Does the emergency contraceptive Plan B work if I'm on a GLP-1?

Levonorgestrel (Plan B) and ulipristal acetate (ella) are single-dose oral medications with the same gastric-emptying concern as an oral contraceptive. Take the dose per the standard instructions on the package; if you vomit within 3 hours, repeat the dose (per the FDA prescribing information for both products). If you want to bypass the oral-absorption issue entirely for emergency contraception, the copper IUD placed within 5 days is the most effective emergency contraceptive available and is unaffected by any GLP-1.

GLP-1 Medications and Birth Control: What to Know (2026)

The one-paragraph answer

Tirzepatide — sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management — carries a formal drug-interaction warning with oral contraceptives on its FDA label. The Eli Lilly tirzepatide prescribing information Section 7 documents an approximately 20 percent reduction in oral-contraceptive area-under-the-curve and roughly a 55 percent drop in peak concentration in the Rasa 2023 pharmacokinetic study, and the label recommends switching to a non-oral hormonal contraceptive or adding a barrier method (condoms) for 4 weeks after starting tirzepatide and after each dose escalation. Semaglutide — Ozempic and Wegovy from Novo Nordisk — does not carry the same labeled warning, but it still slows gastric emptying and warrants a patient-clinician conversation, especially in the first weeks of titration when nausea and vomiting are common. Non-oral hormonal methods (IUD, implant, patch, ring, depot injection) bypass the issue entirely. The rest of this piece walks through the mechanism, the per-drug picture, the practical options, and what this page will not do.

The mechanism (delayed gastric emptying)

GLP-1 receptor agonists work partly by slowing the rate at which the stomach empties into the small intestine. Nauck 2011 (American Journal of Physiology — Endocrinology and Metabolism) documented gastric-emptying delays of roughly 30 to 70 minutes at therapeutic GLP-1 doses in adults without diabetes, and Blundell 2017 (Diabetes Obesity and Metabolism) reproduced the same effect with semaglutide. The Chao 2023 subanalysis of tirzepatide gastric-emptying data confirmed that tirzepatide produces the largest gastric-emptying delay of the currently approved GLP-1s, with the effect most pronounced after the first dose and each escalation and attenuating after roughly 4 weeks of stable dosing.

Oral contraceptives — both combined and progestin-only pills — depend on complete absorption from the small intestine over 1 to 2 hours to hit the blood-level threshold needed for consistent ovulation suppression. Flatten that absorption curve enough and the peak drops below the threshold. The pill has not disappeared — total absorbed is only ~20 percent lower for tirzepatide — but the peak level, which drives the pharmacology, drops by roughly half in the first days after each dose change. That is why the FDA-labeled precaution is time-limited to a 4-week window, not a permanent contraindication.

For the day-to-day GI effects, see managing GLP-1 side effects and food noise and GLP-1s.

Per-drug interaction table

The single most important row is the top one. The other rows are “no labeled barrier requirement, but the physiology is directionally the same — use judgment.” For a head-to-head on the drugs themselves see the GLP-1 medications compared hub and Mounjaro vs Zepbound.

Why tirzepatide is different — the SURPASS OC-interaction study

The Rasa 2023 Lilly-sponsored pharmacokinetic study, cited in the tirzepatide prescribing information, dosed 20 healthy adult participants with a single 5 mg tirzepatide injection followed by a standard norgestimate-plus-ethinyl-estradiol combined oral contraceptive. The results:

• Oral-contraceptive area-under-the-curve fell by roughly 20 percent.
• Peak plasma concentration (Cmax) fell by roughly 55 percent.
• The effect was largest on the first dose and after each subsequent escalation.
• The effect attenuated by roughly week 4 after each dose change.

That “largest on the first dose and after each escalation” pattern is why the label recommendation is 4 weeks after starting and 4 weeks after every step-up — not a one-time backup period. Because tirzepatide titrates from 2.5 mg to 5, 7.5, 10, 12.5, and 15 mg with a new step roughly every 4 weeks, the barrier-backup periods effectively overlap through much of the titration. For many patients, this is the point at which a non-oral method starts to look simpler than juggling barrier windows across five consecutive escalations.

Non-oral hormonal contraceptive alternatives (the practical option list)

Every method in this table bypasses the gastric-emptying issue entirely — none of them depend on gut absorption.

For readers on tirzepatide who plan to continue for more than about 6 months, switching to one of these methods is often the simplest long-term move. It removes the barrier-window bookkeeping and takes the “did I miss a pill because I was nauseated?” question off the table.

When barrier backup is enough (the short-term window)

Barrier backup — condoms, ideally with spermicide — for 4 weeks after each tirzepatide dose change is enough for readers who are on a short microdose plan (see GLP-1 microdosing) and expect to stop dose escalations within a few months, already use dual protection routinely, or prefer not to switch methods for a defined, short GLP-1 course. The honest catch: those 4-week windows overlap through the entire titration if you step up on schedule, so if barrier backup starts to feel like a full-time job, that is the signal to consider a non-oral method for the duration.

Semaglutide, dulaglutide, liraglutide — the “no label warning” nuance

The Novo Nordisk labels for semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Saxenda, Victoza), and the Eli Lilly label for dulaglutide (Trulicity), do not carry an oral-contraceptive interaction warning in the Drug Interactions section. The pharmacokinetic studies on these drugs did not reproduce the tirzepatide-magnitude reduction in oral-contraceptive AUC and Cmax. That is the reason there is no labeled recommendation to add a barrier method.

But “no label warning” is not “no effect.” Semaglutide still slows gastric emptying by 30 to 70 minutes at therapeutic doses (Blundell 2017), and postmarketing reports do include breakthrough bleeding on semaglutide-plus-OC and rare unintended pregnancies. The practical read:

• On a non-oral method (IUD, implant, patch, ring, depot injection), no change is needed.
• On an oral contraceptive and want extra confidence: a barrier method for 4 weeks after each dose step-up is a reasonable conservative default.
• Switching from semaglutide to tirzepatide (see switching GLP-1 medications) turns the labeled barrier-backup rule on the moment you take the first tirzepatide dose.

For which contraceptives change weight and which do not, see birth control and weight changes.

The vomiting and diarrhea rule (any GLP-1)

Nausea, vomiting, and diarrhea are common in the first 4 to 8 weeks of any GLP-1 titration and again after each dose escalation. The routine mitigation strategies are covered in managing GLP-1 side effects. For contraception purposes:

• Vomiting within 3 hours of taking your pill — the dose almost certainly did not absorb. Treat the day as a missed pill and follow the missed-pill instructions on your specific pill pack, which for most combined pills means take another pill from a backup pack, continue on your normal schedule, and use a barrier method for the next 7 days.
• Vomiting more than 3 hours after taking your pill — the pill has usually absorbed; no action needed.
• Diarrhea alone — usually does not affect oral-contraceptive absorption unless it is severe (more than 4 to 6 loose stools per day) or prolonged (more than 24 hours). If it is severe, treat the day as a missed pill.

This is the same missed-pill rule that applies during any stomach bug — the GLP-1 does not create a new rule; it makes the underlying rule more likely to matter.

Pregnancy planning and GLP-1 washout

All approved GLP-1s are contraindicated during pregnancy. The Novo Nordisk labels for Wegovy, Ozempic, and Saxenda, and the Eli Lilly labels for Zepbound and Mounjaro, all recommend discontinuation at least 2 months before planned conception. The washout period is driven by drug half-life:

• Semaglutide half-life ~7 days — 2 months clears to roughly 5 percent of steady-state.
• Tirzepatide half-life ~5 days — 2 months clears to roughly 1 percent of steady-state.
• Liraglutide half-life ~13 hours — cleared within days.

The framing to bring to your prescriber is a stop-date, not a surprise: if conception is in the near-term horizon, plan the discontinuation. Readers thinking about weight and pregnancy timing together will also find weight loss after pregnancy useful for the post-birth side of the same conversation.

The return of appetite and food noise after stopping is real and predictable — see rebound weight gain after stopping GLP-1. If pregnancy is possible but not planned, staying on effective contraception through the whole washout matters; the 2-month washout is measured from the last dose forward.

Emergency contraception on a GLP-1

Levonorgestrel (Plan B, Take Action, My Way) and ulipristal acetate (ella) are both single-dose oral emergency contraceptives, and both share the same gastric-emptying concern as any oral pill on a GLP-1. Practical guidance:

• Take the dose per the standard instructions on the package (Plan B: within 72 hours; ella: within 120 hours).
• If you vomit within 3 hours of the dose, repeat the dose, per the FDA prescribing information for both products.
• The copper IUD placed within 5 days of unprotected intercourse is the most effective emergency contraceptive available (roughly 99 percent effective) and is entirely unaffected by any GLP-1. It also becomes an ongoing contraceptive method afterward.

For readers on a GLP-1 who anticipate any emergency-contraception scenarios, keeping a copper-IUD provider phone number in your notes app is a practical hedge.

What this page will not do

• It will not name a specific brand of oral contraceptive or IUD for you. Method choice depends on your medical history, migraine profile, VTE risk, bleeding pattern, insurance formulary, and preference — a prescriber conversation.
• It will not tell you to stop or start any medication. The GLP-1 decision and the contraceptive-method decision are separate; both go through your prescriber.
• It will not substitute for that face-to-face conversation. The purpose of this page is to walk you into the appointment already knowing the tirzepatide barrier-backup rule, the tirzepatide-vs-semaglutide label difference, and the non-oral options — so the visit moves quickly to your specific situation.

The clinicians best positioned to have this conversation are the endocrinologist or obesity-medicine physician prescribing the GLP-1 and the OB/GYN or family-medicine clinician managing your contraception. If those are two different offices, telling each about the other is on you.

GLP-1 and Birth Control FAQ

Does Ozempic affect birth control pills? No labeled warning, but semaglutide slows gastric emptying — a barrier method for 4 weeks after each escalation is a reasonable conservative default if you rely on an oral contraceptive.

Does Mounjaro or Zepbound affect birth control pills? Yes — the FDA-labeled recommendation is a non-oral method or barrier backup for 4 weeks after initiation and after each dose escalation.

How long is the barrier-backup window? 4 weeks after each tirzepatide dose change; effectively continuous through the titration for on-schedule dose escalations.

Are IUDs affected by GLP-1s? No — IUDs, implants, patches, rings, and depot injections all bypass gastric absorption entirely.

What if I vomit after taking my pill on a GLP-1? Vomiting within 3 hours = treat as a missed pill and use barrier backup for 7 days.

Can I get pregnant on a GLP-1? Yes — GLP-1s are not contraceptive, are contraindicated in pregnancy, and unintended pregnancies on GLP-1s are being reported more frequently.

How long before trying to conceive should I stop a GLP-1? At least 2 months per the FDA labels for Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda.

Does Plan B work on a GLP-1? Yes — take per package instructions and repeat the dose if you vomit within 3 hours; a copper IUD within 5 days is the highest-efficacy alternative.